Kinetic analysis of PI3K reactions with fluorescent PIP2 derivatives
Authors:
- 26 July 2011
- journal article
- research article
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 401 (6) , 1881-1888
Abstract
Phosphatidylinositol 3-kinase (PI3K) signaling plays important roles in cell differentiation, proliferation, and migration. Increased mutations and expression levels of PI3K are hallmarks for the development of certain cancers. Pharmacological targeting of PI3K activity has also been actively pursued as a novel cancer therapeutic. Consequently, measurement of PI3K activity in different cell types or patient samples holds the promise as being a novel diagnostic tool. However, the direct measurement of cellular PI3K activity has been a challenging task. We report here the characterization of two fluorescent PIP2 derivatives as reporters for PI3K enzymatic activity. The reporters are efficiently separated from their corresponding PI3K enzymatic products through either thin layer chromatography (TLC) or capillary electrophoresis (CE), and can be detected with high sensitivity by fluorescence. The biophysical and kinetic properties of the two probes are measured, and their suitability to characterize PI3K inhibitors is explored. Both probes show similar capacity as PI3K substrates for inhibitor characterization, yet also possess distinct properties that may suggest their different applications. These characterizations have laid the groundwork to systematically measure cellular PI3K activity, and have the potential to generate molecular fingerprints for diagnostic and therapeutic applications. Fluorescent PIP2 is efficiently phosphorylated by PI3K to form fluorescent PIP3. Consequently, PI3K activity can be measured by separating and quantifying fluorescent PIP2 and PIP3Keywords
This publication has 35 references indexed in Scilit:
- Drugging the PI3 Kinome: From Chemical Tools to Drugs in the ClinicCancer Research, 2010
- The PI3K Pathway As Drug Target in Human CancerJournal of Clinical Oncology, 2010
- Phosphoinositide Signaling: New Tools and InsightsPhysiology, 2009
- Targeting the phosphoinositide 3-kinase pathway in cancerNature Reviews Drug Discovery, 2009
- PI3K pathway alterations in cancer: variations on a themeOncogene, 2008
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Mechanisms of Disease: the PI3K–Akt–PTEN signaling node—an intercept point for the control of angiogenesis in brain tumorsNature Clinical Practice Neurology, 2007
- Separation of fluorescent phosphatidyl inositol phosphates by CEElectrophoresis, 2007
- Human Tumor Mutants in PI3K p110α SubunitCell Cycle, 2006
- Synthesis of Photoactivatable 1,2-O-Diacyl-sn-glycerol Derivatives of 1-l-Phosphatidyl-d-myo-inositol 4,5-Bisphosphate (PtdInsP2) and 3,4,5-Trisphosphate (PtdInsP3)The Journal of Organic Chemistry, 1996